XML 28 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Segment Information
9 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
1
1
-
S
egment Information
 
We have
four
reporting segments:
Sterilization and Disinfection Control (formerly named Biological Indicators), Instruments, Cold Chain Monitoring and Cold Chain Packaging. The following tables set forth our segment information (in thousands):
 
   
Three Months Ended December 31
, 2017
 
   
Sterilization
and
Disinfection
Control
   
 
 
 
Instruments
   
 
 
Cold Chain
Monitoring
   
 
 
Cold Chain
Packaging
   
Total
 
Revenues
  $
10,630
    $
8,182
    $
3,267
    $
1,592
    $
23,671
 
                                         
Gross profit (loss)
  $
7,134
    $
5,150
    $
(43
)   $
440
     
12,681
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(23,207
)
Loss
before income taxes
   
 
     
 
     
 
     
 
    $
(10,526
)
 
   
Three Months Ended December 31
, 2016
 
   
Sterilization
and
Disinfection
Control
   
 
 
 
Instruments
   
 
 
Cold Chain
Monitoring
   
 
 
Cold Chain
Packaging
   
Total
 
Revenues
  $
9,248
    $
9,013
    $
3,102
    $
2,480
    $
23,843
 
                                         
Gross profit
  $
6,066
    $
5,706
    $
1,254
    $
511
     
13,537
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(9,657
)
Earnings
before income taxes
   
 
     
 
     
 
     
 
    $
3,880
 
 
   
Nine Months Ended December 31
, 2017
 
   
Sterilization
and
Disinfection
Control
   
 
 
 
Instruments
   
 
 
Cold Chain
Monitoring
   
 
 
Cold Chain
Packaging
   
Total
 
Revenues
  $
30,798
    $
24,768
    $
9,335
    $
4,397
    $
69,298
 
                                         
Gross profit
  $
20,676
    $
15,021
    $
2,044
    $
844
     
38,585
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(44,702
)
Loss
before income taxes
   
 
     
 
     
 
     
 
    $
(6,117
)
 
   
Nine Months Ended December 31
, 2016
 
   
Sterilization
and
Disinfection
Control
   
 
 
 
Instruments
   
 
 
Cold Chain
Monitoring
   
 
 
Cold Chain
Packaging
   
Total
 
Revenues
  $
27,612
    $
25,928
    $
8,964
    $
6,862
    $
69,366
 
                                         
Gross profit
  $
17,986
    $
15,881
    $
3,578
    $
1,830
     
39,275
 
Reconciling items
(1)
   
 
     
 
     
 
     
 
     
(30,014
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
9,261
 
 
 
(
1
)
Reconciling items include
selling, general and administrative, research and development, impairment and other expenses
 
   
December
3
1
, 201
7
   
March 31,
201
7
 
Total assets
(in thousands):
               
Sterilization and Disinfection Control
  $
83,101
    $
67,233
 
Instruments
   
33,819
     
40,805
 
Cold Chain Monitoring
   
31,198
     
35,789
 
Cold Chain Packaging
   
7,381
     
20,313
 
Corporate and administrative
   
12,278
     
7,593
 
    $
167,777
    $
171,733
 
 
All long-lived assets are located in the United State
s except for
$5,823,000,
$7,484,000
and
$16,807,000
which are associated with our French, Canadian and German subsidiaries, respectively.
 
R
evenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):
 
   
Three
M
onths
E
nded
December
3
1
,
   
Nine Months Ended
December
3
1
,
 
   
201
7
   
201
6
   
201
7
   
201
6
 
Net revenues from unaffiliated customers:
                               
United States
  $
14,221
    $
13,844
    $
41,664
    $
44,758
 
Foreign
   
9,450
     
9,999
     
27,634
     
24,608
 
    $
23,671
    $
23,843
    $
69,298
    $
69,366
 
 
No
foreign country exceeds
10
percent of total revenues.